How drug delivery methods have evolved to deliver complex formulations using multiparticulate technology - with a focus on extrusion-spheronisation coated bead technology.
Paul O’Donohoe, Scientific Lead, eCOA and Mobile Health at Medidata explores how using digital platforms and remote solutions can give the broadest picture of patient response.
European Pharmaceutical Manufacturer speaks to Dr Henry Skinner, CEO of the AMR Action Fund about dangers of AMR, why new incentives are needed for antibiotic development and what the Fund is doing to bring about new antibiotics.
Richard Porter, pharmaceutical director at AspenTech looks at how automated technologies are helping pharma companies transform their manufacturing processes.
EPM speaks to the Life Science business of Merck to learn about the company's initiative to implement a sustainability framework across its entire R&D network.
Dr Clive Glover, director, Strategy, Pall Corporation discusses recent industry developments surrounding cell and gene therapies and why safety is a key priority for this treatment area.
Ian and Reece are back, though they might be tripping over and getting their words muddled up, they talk about Covid-19 vaccine approvals, the EU's pandemic predicament and why Trump is back in the news.
Ian and Reece are back to discuss more news related to the pandemic, as well as another potential re-organisation in the NHS, investment in the UK life sciences sector and another report surrounding the digitisation of healthcare.
